September 15, 2011 | by Nobel Biocare Management AG
|
Reading time: 1 minute
September 15, 2011, obel Biocare has successfully launched its inaugural CHF-denominated domestic straight bond issue in the aggregate principal amount of CHF 120 million with a coupon of 4%, due 10 October 2016.
Nobel Biocare will use the bond proceeds to partially refinance the outstanding convertible bond, which becomes due in November 2011. Nobel Biocare views this bond issue as a particular success given the current, highly volatile market environment.
Contact
Nobel Biocare Management AG P.O. Box 8058 Zurich-Airport Nicolas Weidmann Senior Vice President Communications Tel. 043 211 42 80 Mobile: 079 372 29 81 Fax 043 211 42 42 E-mail: nicolas.weidmann@nobelbiocare.com
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Nobel Biocare successfully launches a CHF 120 million domestic straight bond issue »
Source: Nobel Biocare Management AG, Press release